Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
Discussion + Q&A

Session: Real World/Road Rules Challenge: Implementation of Long-Acting ART

572 - Insurance Changes Are Common and Associated with Delayed Cabotegravir Plus Rilpivirine Injections

Wednesday, October 22, 2025
10:30 AM - 10:42 AM US ET
Location: B203

    Presenting Author(s)

  • Jennifer M. Davis, MD (she/her/hers)

    Assistant Professor
    University of Nebraska Medical Center
    Omaha, NE, United States

    Slides

    • Co-Author(s)

  • Sara H. Bares, MD

    Associate Professor, Division of Infectious Diseases
    University of Nebraska Medical Center
    Omaha, NE, United States

  • JO

    Jennifer O'Neill, BSN, RN

    Long-Acting Injectable Therapy Coordinator
    University of Nebraska Medical Center
    Omaha, Nebraska, United States

  • EL

    Elizabeth Lyden, MS

    Associate Director, Center for Collaboration on Research, Design and Analysis
    University of Nebraska Medical Center
    Omaha, Nebraska, United States

Disclosure(s):
Jennifer M. Davis, MD: GSK/ViiV Healthcare: Grant/Research Support
Sara H. Bares, MD: Gilead Sciences: Expert Testimony